REGENXBIO Inc.

RGNX Nasdaq SEC CIK 1590877
Follow Regenxbio Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $9.2M −69.2% vs same quarter last year
Net income −$40.7M +34.2% vs same quarter last year
EPS, diluted −$0.62 +48.3% vs same quarter last year
Operating cash flow $38.6M +169% vs same quarter last year
Revenue by quarter
$21.2M
$89M
$21.4M
$29.7M
$30.3M
$6.4M
$108M
$9.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income14 fiscal years
  • Revenue
  • Net income
−$400M−$200M$0$200M$400M$600MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$170.4M−$193.9M
FY24$83.3M−$227.1M
FY23$90.2M−$263.5M
FY22$112.7M−$280.3M
FY21$470.3M$127.8M
FY20$154.6M−$111.3M
FY19$35.2M−$94.7M
FY18$218.5M$99.9M
FY17$10.4M−$73.2M
FY16$4.6M−$63M
FY15$7.6M−$22.8M
FY14$6.1M−$4M
FY13$6.1M−$5.4M
FY12--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1500%−1000%−500%0%500%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25-−94.6%−113.8%
FY2459.7%−280%−272.5%
FY2358.8%−297.1%−292%
FY2251.6%−233.2%−248.7%
FY2189%34%27.2%
FY2076.9%−77.1%−72%
FY1976.6%−422.9%−268.9%
FY1895.6%40.3%45.7%
FY1783.6%−730.2%−704%
FY1697.9%−1423.8%−1372.1%
FY1598.7%−304.9%−300.6%
FY1498%−60.2%−65.4%
FY1397.2%−78.5%−88.5%
FY12---
Free cash flowOperating cash flow minus capital expenditure
−$300M−$200M−$100M$0$100M$200MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$126.4M
FY24−$175.6M
FY23−$228.4M
FY22−$238.2M
FY21$134.7M
FY20−$80.9M
FY19−$119.4M
FY18$91.4M
FY17−$65.2M
FY16−$56.7M
FY15−$23M
FY14-
FY13-
FY12-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Regenxbio
  • Healthcare median
−1500%−1000%−500%0%500%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRegenxbioHealthcare median
FY25−113.8%−30.6%
FY24−272.5%−47%
FY23−292%−58%
FY22−248.7%−80.4%
FY2127.2%−71.8%
FY20−72%−62.2%
FY19−268.9%−46.2%
FY1845.7%−49.6%
FY17−704%−45.9%
FY16−1372.1%−36%
FY15−300.6%−37.8%
FY14−65.4%−35.5%
FY13−88.5%−37.1%
FY12-−29.1%